Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study.
Earley, Willie
Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study. [electronic resource] - The American journal of psychiatry 06 2019 - 439-448 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1535-7228
10.1176/appi.ajp.2018.18070824 doi
Adult
Antipsychotic Agents--therapeutic use
Bipolar Disorder--drug therapy
Depression--drug therapy
Double-Blind Method
Female
Humans
Male
Middle Aged
Piperazines--therapeutic use
Receptor, Serotonin, 5-HT1A
Receptors, Dopamine D2--agonists
Receptors, Dopamine D3--agonists
Serotonin 5-HT1 Receptor Agonists--therapeutic use
Treatment Outcome
Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study. [electronic resource] - The American journal of psychiatry 06 2019 - 439-448 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1535-7228
10.1176/appi.ajp.2018.18070824 doi
Adult
Antipsychotic Agents--therapeutic use
Bipolar Disorder--drug therapy
Depression--drug therapy
Double-Blind Method
Female
Humans
Male
Middle Aged
Piperazines--therapeutic use
Receptor, Serotonin, 5-HT1A
Receptors, Dopamine D2--agonists
Receptors, Dopamine D3--agonists
Serotonin 5-HT1 Receptor Agonists--therapeutic use
Treatment Outcome